Literature DB >> 10722581

Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.

P S Turaga1, T J Tierney, K E Bennett, M C McCarthy, S C Simonek, P A Enyong, D W Moukatte, S Lustigman.   

Abstract

Antigen-specific interleukin-5 (IL-5), gamma interferon (IFN-gamma), and granulocyte-macrophage colony-stimulating factor (GM-CSF) responses in individuals living in an area of hyperendemicity for onchocerciasis in Cameroon were examined. The responses against antigens prepared from Onchocerca volvulus third-stage larvae (L3), molting L3 (mL3), and crude extract from adult males (M-OvAg) were compared to the responses against antigens from adult female worms and skin microfilariae. Cytokine responses for the putatively immune individuals (PI) and the infected individuals (INF) were compared. A differential cytokine profile of IL-5 (Th2 phenotype) and IFN-gamma (Th1 phenotype) was found in these individuals in response to the antigens. In both the PI and the INF, Th2 responses against all the antigens tested were dominant. However, in the PI group as a whole, there was an enhanced Th2 response against the larval antigens and the adult male and adult female antigens, and a Th1 response in a subgroup of the PI (27 to 54.5%) against L3, mL3, and M-OvAg antigens was present. While the PI produced significantly higher levels of GM-CSF against L3, mL3, and M-OvAg antigens than the INF, there was no difference in the GM-CSF responses of the groups against the other antigens. The present study indicated that, in comparison to the INF, the PI have distinct larva-specific and adult male-specific cytokine responses, thus supporting the premise that immunological studies of the PI would lead to the identification of immune mechanisms and the target genes that play a role in protective immunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722581      PMCID: PMC97365          DOI: 10.1128/IAI.68.4.1905-1911.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Animal models for the study of immunity in human filariasis.

Authors:  J B Lok; D Abraham
Journal:  Parasitol Today       Date:  1992-05

2.  Onchocerca volvulus: biochemical and morphological characteristics of the surface of third- and fourth-stage larvae.

Authors:  S Lustigman; T Huima; B Brotman; K Miller; A M Prince
Journal:  Exp Parasitol       Date:  1990-11       Impact factor: 2.011

3.  The resistance to re-infection of cats repeatedly inoculated with infective larvae of Brugia pahangi.

Authors:  D A Denham; P B McGreevy; R R Suswillo; R Rogers
Journal:  Parasitology       Date:  1983-02       Impact factor: 3.234

4.  Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus.

Authors:  L H Elson; M Calvopiña; W Paredes; E Araujo; J E Bradley; R H Guderian; T B Nutman
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

5.  Infection of IL-4-deficient mice with the parasitic nematode Brugia malayi demonstrates that host resistance is not dependent on a T helper 2-dominated immune response.

Authors:  R A Lawrence; J E Allen; W F Gregory; M Kopf; R M Maizels
Journal:  J Immunol       Date:  1995-06-01       Impact factor: 5.422

Review 6.  Regulation of the immune response in lymphatic filariasis and onchocerciasis.

Authors:  C L King; T B Nutman
Journal:  Immunol Today       Date:  1991-03

7.  A putative protein related to human chemokines encoded antisense to the cDNA of an Onchocerca volvulus antigen.

Authors:  K D Erttmann; D W Büttner; M Y Gallin
Journal:  Trop Med Parasitol       Date:  1995-06

8.  Immunity to onchocerciasis: identification of a putatively immune population in a hyperendemic area of Ecuador.

Authors:  L H Elson; R H Guderian; E Araujo; J E Bradley; A Days; T B Nutman
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

9.  Onchocerca volvulus: application of the polymerase chain reaction to identification and strain differentiation of the parasite.

Authors:  S E Meredith; G Lando; A A Gbakima; P A Zimmerman; T R Unnasch
Journal:  Exp Parasitol       Date:  1991-10       Impact factor: 2.011

10.  Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals.

Authors:  D J Ward; T B Nutman; G Zea-Flores; C Portocarrero; A Lujan; E A Ottesen
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

View more
  24 in total

1.  Protective immunity to the larval stages of onchocerca volvulus is dependent on Toll-like receptor 4.

Authors:  Laura A Kerepesi; Ofra Leon; Sarah Lustigman; David Abraham
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 2.  Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment.

Authors:  Francesca Tamarozzi; Alice Halliday; Katrin Gentil; Achim Hoerauf; Eric Pearlman; Mark J Taylor
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus.

Authors:  D Abraham; O Leon; S Leon; S Lustigman
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

4.  Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries.

Authors:  M Lizotte-Waniewski; W Tawe; D B Guiliano; W Lu; J Liu; S A Williams; S Lustigman
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity.

Authors:  Angus J MacDonald; Prasad S D Turaga; Carolyn Harmon-Brown; Tracy J Tierney; Kristine E Bennett; Maggie C McCarthy; Scott C Simonek; Peter A Enyong; Daniel W Moukatte; Sara Lustigman
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

6.  Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.

Authors:  C S Mai; D M Hamm; M Banla; A Agossou; H Schulz-Key; C Heuschkel; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

Review 7.  Lessons from the genomes and transcriptomes of filarial nematodes.

Authors:  Alexandra Grote; Sara Lustigman; Elodie Ghedin
Journal:  Mol Biochem Parasitol       Date:  2017-01-23       Impact factor: 1.759

8.  In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination.

Authors:  Virginia L Tchakouté; Simon P Graham; Siv Aina Jensen; Benjamin L Makepeace; Charles K Nfon; Leo M Njongmeta; Sara Lustigman; Peter A Enyong; Vincent N Tanya; Albert E Bianco; Alexander J Trees
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

9.  The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.

Authors:  Fidelis Cho-Ngwa; Jing Liu; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2010-08-24

Review 10.  Acquired immune heterogeneity and its sources in human helminth infection.

Authors:  C D Bourke; R M Maizels; F Mutapi
Journal:  Parasitology       Date:  2010-10-15       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.